f Lysozyme is a key component of the innate immune response in humans that provides a first line of defense against microbes. The bactericidal effect of lysozyme relies both on the cell wall lytic activity of this enzyme and on a cationic antimicrobial peptide activity that leads to membrane permeabilization. Among Gram-positive bacteria, the opportunistic pathogen Enterococcus faecalis has been shown to be extremely resistant to lysozyme. This unusual resistance is explained partly by peptidoglycan Oacetylation, which inhibits the enzymatic activity of lysozyme, and partly by D-alanylation of teichoic acids, which is likely to inhibit binding of lysozyme to the bacterial cell wall. Surprisingly, combined mutations abolishing both peptidoglycan O-acetylation and teichoic acid alanylation are not sufficient to confer lysozyme susceptibility. In this work, we identify another mechanism involved in E. faecalis lysozyme resistance. We show that exposure to lysozyme triggers the expression of EF1843, a protein that is not detected under normal growth conditions. Analysis of peptidoglycan structure from strains with EF1843 loss-and gain-of-function mutations, together with in vitro assays using recombinant protein, showed that EF1843 is a peptidoglycan N-acetylglucosamine deacetylase. EF1843-mediated peptidoglycan deacetylation was shown to contribute to lysozyme resistance by inhibiting both lysozyme enzymatic activity and, to a lesser extent, lysozyme cationic antimicrobial activity. Finally, EF1843 mutation was shown to reduce the ability of E. faecalis to cause lethality in the Galleria mellonella infection model. Taken together, our results reveal that peptidoglycan deacetylation is a component of the arsenal that enables E. faecalis to thrive inside mammalian hosts, as both a commensal and a pathogen.
E
nterococci are Gram-positive commensal bacteria commonly found in the gastrointestinal and vaginal tracts and in the oral cavity of humans and other mammals. Over the last decades, Enterococcus faecalis has emerged as a leading cause of life-threatening nosocomial infections (23) . Due to its large range of intrinsic and acquired antibiotic resistances, E. faecalis infections can be difficult to treat and are associated with substantial health care costs. In addition to the high capacity of E. faecalis to resist harsh conditions and a wide range of stresses (19) , genome-wide analyses of clinical isolates suggested that the genome plasticity of this bacterium also contributes to its ability to survive both as a commensal and as an opportunistic pathogen (33, 37) . One of the properties enabling E. faecalis to survive within the mammalian host is an extreme resistance to lysozyme, one of the most important and widespread components of innate immunity (9) . Lysozyme is found in a wide range of body fluids (e.g., tears, saliva, and urine) and tissues (e.g., respiratory and intestinal tract tissues) and is produced by neutrophils and macrophages (7, 13, 17, 29) . The bactericidal activity of lysozyme is due both to the cell wall lytic activity of this enzyme [cleavage of ␤-(1,4)-glycosidic bonds between N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc) residues in peptidoglycan] and to a nonenzymatic mechanism involving its cationic antimicrobial peptide (CAMP) properties that lead to membrane permeabilization (25, 27) . To counteract both modes of action of lysozyme, Gram-positive bacteria have developed two major mechanisms: (i) modification of the peptidoglycan structure through peptidoglycan GlcNAc deacetylation (6, 43) or MurNAc O-acetylation (4, 10, 24) and (ii) modification of the negative net charge of the bacterial cell envelope to decrease binding of cationic lysozyme to the cell. The latter mechanism is mediated by dlt genes, adding positively charged D-alanine residues on both teichoic and lipoteichoic acids (24, 34) , or the multiple peptide resistance factor MprF, adding L-lysine on phosphatidylglycerol (16) .
Previous studies have shown that E. faecalis is highly resistant to lysozyme, with a MIC above 50 mg/ml. This extreme resistance has been partly explained by an additive effect of both peptidoglycan O-acetylation and cell wall D-alanylation (24, 30) . It was also shown that full lysozyme resistance requires a signaling cascade involving the extracytoplasmic function (ECF) sigma factor SigV. Previous studies revealed that the E. faecalis genome encodes a putative peptidoglycan deacetylase (EF1843). Although deletion of EF1843 was associated with a decreased persistence in mouse peritoneal macrophages, no phenotype associated with this deletion could be shown (24) . In this work, we identified the mechanism by which sigV signaling contributes to ly-sozyme resistance. We show that exposure to lysozyme triggers SigV-dependent expression of the peptidoglycan GlcNAc deacetylase EF1843 (PgdA) in E. faecalis JH2-2. PgdA-mediated peptidoglycan deacetylation is shown to contribute not only to lysozyme resistance but also to virulence of E. faecalis in a Galleria mellonella insect model.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. Bacterial strains and plasmids used in this study are listed in Table S1 in the supplemental material. E. faecalis was grown at 37°C without shaking in M17 medium supplemented with 0.5% glucose (GM17) (38) or in brain heart infusion (BHI). Escherichia coli was grown with vigorous shaking at 37°C in Luria-Bertani (LB) medium (36) . When required, erythromycin or ampicillin was added for E. faecalis or E. coli cultures, respectively.
DNA manipulations. General molecular methods, molecular cloning, and other standard techniques were performed essentially as described in reference 36. Electrocompetent cells of E. coli or E. faecalis (11) were transformed by electroporation using a Gene Pulser apparatus (Bio-Rad Laboratories). Plasmids and PCR products were purified using Qiagen kits (Qiagen, Valencia, CA).
Plasmid construction for protein expression and gene deletion. PgdA (301 residues) has a putative N-terminal signal peptide of 41 amino acids (24) . Recombinant PgdA corresponding to the extracellular portion of the protein was overexpressed in E. coli to raise specific antibodies. pQE1843, encoding a polypeptide corresponding to residues 44 to 301 of PgdA, was constructed as follows. The DNA fragment encoding PgdA was PCR amplified with primers LH20 and Pgd19 (see Table S1 in the supplemental material) using E. faecalis JH2-2 genomic DNA as a template. The resulting PCR product was digested by BamHI and PstI and cloned into the pQE31 vector (Qiagen) (see Table S1 ). The construction of pgdMAD, a pMAD derivative with inactivation of the gene encoding PgdA, was done as previously described (24) . The following primers, listed in Table S1 , were routinely used to check gene deletions: Pgd12 and Pgd19 for EF1843, LH41 and LH43 for EF0783, Dlt16 and Dlt17 for EF2749, and Sig7 and Sig8 for EF3180.
Complementation of the E. faecalis ⌬pgdA mutant was obtained by cloning the cognate pgdA gene into pVE3916, a pWV01 derivative (41, 42) . A 1,276-bp DNA fragment was PCR amplified from the E. faecalis JH2-2 chromosome with primers LH47 and LH48 (see Table S1 in the supplemental material). The resulting fragment, including 173 bp upstream of the coding sequence of pgdA that contained the promoter, was digested with XhoI and HindIII restriction enzymes and cloned into pVE3916 similarly digested. The resulting plasmid (pVEF1843) was transformed into the E. faecalis ⌬pgdA mutant. E. faecalis JH2-2 and its ⌬pgdA derivative mutant were transformed with the empty pVE3916 plasmid.
In vitro deacetylation assays. Chitooligosaccharides (Dextra Laboratories Ltd.; catalog numbers C8002, C8003, C8004, C8005, and C8006) were used at a concentration of 500 M. Deacetylation assays were carried out for 6 h at 37°C using 10 mM phosphate buffer (pH 7.5) containing 250 M CoCl 2 in a final reaction volume of 100 l. Recombinant PgdA was added at a concentration of 15 M, except for dose-response experiments (see Fig. 3 ). Reaction products were reduced as described below for peptidoglycan before mass spectrometry (MS) analyses.
Construction of JH2-2 derivative mutants. Isogenic mutants of E. faecalis JH2-2 were constructed by allelic exchange using the procedure previously described (24) . The quadruple mutant ⌬oatA ⌬sigV ⌬dltA ⌬pgdA was constructed by introducing the ⌬pgdA deletion in a ⌬oatA ⌬sigV ⌬dltA background (30) using plasmid pgdMAD. Inducible expression of sigV under the control of nisin was carried out using plasmid pMSP3535-sigV, a pMSP3535 derivative (see Table S1 in the supplemental material).
Cell wall purification and peptidoglycan structural analysis. Peptidoglycan was purified from exponentially growing cells as described previously (14) , freeze-dried, and resuspended in distilled water at a concentration of 20 mg/ml. Peptidoglycan (5 mg) was digested overnight with 250 g of mutanolysin at 37°C in 500 l of 20 mM sodium phosphate buffer (pH 6.0). Soluble disaccharide peptides were recovered in the supernatant following centrifugation (20,000 ϫ g for 20 min at 25°C) and reduced with sodium borohydride as described previously (14) . The reduced muropeptides were separated by reverse-phase high-performance liquid chromatography (rp-HPLC) on a C 18 column (3-m particles, 4.6 by 250 mm; Interchrom, Montluçon, France) at a flow rate of 0.5 ml/min. After 10 min in 10 mM ammonium phosphate, pH 5.6 (buffer A), muropeptides were eluted with a 270-min linear methanol gradient (0 to 30%) in buffer A. The peaks were analyzed by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) with a Voyager DE STR mass spectrometer (Applied Biosystems, Framingham, MA), using ␣-cyano-4-hydroxycinnamic acid as a matrix. For tandem mass spectrometry (MS-MS), data were collected with an electrospray time of flight mass spectrometer operating in the positive mode (Qstar Pulsar I; Applied Biosystems). The data were acquired with a capillary voltage of 5,200 V and a declustering potential of 20 V. The mass scan range was from m/z 350 to 1,500, and the scan cycle was 1 s.
PgdA protein production and purification. E. faecalis PgdA was overexpressed and purified as a recombinant protein with an N-terminal 6ϫHis tag. E. coli BL21(DE3) cells harboring plasmid pQEF1843 were grown at 37°C in BHI broth. When the cultures had reached an optical density at 600 nm (OD 600 ) of 0.7, production of the recombinant proteins was induced by addition of 0.5 mM isopropyl-␤-D-thiogalactopyranoside, and incubation was continued for 4 h. The cells were harvested and resuspended in buffer A (50 mM Tris-HCl [pH 8.0] containing 300 mM NaCl), and crude lysates were obtained by sonication (five times for 30 s, 20% output; Branson Sonifier 450). Proteins were loaded onto Ni 2ϩ -nitrilotriacetate agarose resin (Qiagen GmbH, Hilden, Germany), washed with 10 mM imidazole in buffer A, and eluted with 300 mM imidazole in buffer A. Recombinant His-tagged proteins were further purified by size exclusion chromatography on a Superdex75 HR 26/60 column (Amersham Biosciences, Uppsala, Sweden) equilibrated with a buffer containing 50 mM Na 2 HPO 4 , 150 mM NaCl, and 0.5 mM CoCl 2 (pH 7.5). The fractions were analyzed by sodium dodecyl sulfate-polyacrymamide gel electrophoresis (SDS-PAGE) and pooled (see Fig. S1 in the supplemental material). Protein concentration was estimated by measuring absorbance using a theoretical extinction coefficient of 41,370 M Ϫ1 cm Ϫ1 at 280 nm. Recombinant EF1843 protein was kept frozen at Ϫ80°C after addition of 25% (vol/vol) glycerol.
Western blotting. Immune rabbit serum against recombinant Histagged EF1843 was generated by intramuscular immunization with the protein dialyzed against phosphate-buffered saline buffer at the GIP Plateforme Technologique d'Evreux (Evreux, France). For Western blot analyses, 10-ml samples of bacterial cultures were harvested at an OD 600 of 0.5 by centrifugation. Cells were resuspended in 150 l of 0.25 M Tris-HCl buffer (pH 7.5) and broken by vortexing for 3 min after addition of glass beads (0.1-to 0.25-mm diameter). Unbroken cells were removed by centrifugation (10 min at 6,000 ϫ g, 4°C), and protein concentration was determined using the Bio-Rad protein assay (Bio-Rad Laboratories). Crude extracts (10 g) were separated by SDS-PAGE and transferred onto a polyvinylidene difluoride membrane using the Bio-Rad transblot system. The membranes were probed with anti-PgdA rabbit polyclonal serum at a 1/2,000 dilution. Western blots were developed using the enhanced chemiluminscence (ECL) detection kit (GE Healthcare, Little Chalfont, United Kingdom), according to the manufacturer's instructions.
Lysozyme sensitivity assay. Lysozyme sensitivity of the deletion mutants (see Fig. 4A ) was assayed on LB agar supplemented with hen egg white lysozyme (Fluka, Buchs, Switzerland). Overnight cultures were harvested by centrifugation (5,000 ϫ g for 5 min at room temperature), washed once in saline water (0.9% [wt/vol] NaCl), and resuspended to an OD 600 of 1. Two microliters of the 10 Ϫ1 , 10 Ϫ2 , and 10 Ϫ3 dilutions was spotted on LB agar supplemented with 0.5 mg/ml or 0.75 mg/ml of lysozyme.
The contribution of PgdA to lysozyme resistance was monitored on gradient plates (see Fig. 4B ) as follows: overnight cultures were diluted, and the cell suspension corresponding to 10 Ϫ2 dilutions (ca. 10 6 CFU/ml) was streaked on a square petri dish containing a gradient of concentrations of nisin (up to 0.5 g/ml) and lysozyme (up to 5 mg/ml) in opposite directions. The plates were photographed after 48 h of incubation at 37°C.
For semiquantitative assays (see Fig. S4 in the supplemental material), overnight cultures were prepared, and 2 l each of the 10 Ϫ1 , 10 Ϫ2 , and 10 Ϫ3 dilutions was spotted on LB agar containing 0.5 g/ml of nisin and supplemented with different concentrations of lysozyme. The plates were photographed after 48 h of incubation at 37°C.
G. mellonella larva infection. G. mellonella larvae were reared on bee's wax and pollen at 28°C in the dark. Larvae measuring 2.0 to 2.5 cm in length (body weight, 200 to 300 mg) with a cream-colored cuticle with minimal speckling or discoloration were used for each experiment. The E. faecalis strains used for infection were grown for 24 h in GM17. After centrifugation, cells were washed twice in 0.9% NaCl and resuspended to a final OD 600 of 0.3. The size of the inoculums was confirmed by determining the number of CFU on solid GM17. Cohorts of 20 larvae were infected with 10 l of a cell suspension through the left hindmost proleg into the hemocoel using a microinjector (KDS 100; KD Scientific) with a 1-ml syringe and 0.45-by 12-mm needles (Terumo). Five infected larvae were kept per petri dish, without food, at 37°C, and survival was monitored for 24 h by scoring every 2 h after 16 h of infection. As a negative control, the first and last cohort of infected larvae in every assay was sham infected with sterile 0.9% (wt/vol) NaCl solution. Larvae were considered dead when they displayed no movement in response to touch and had turned black.
Statistical analyses. Survival curves were analyzed with GraphPad Prism 5 using the log rank test.
RESULTS

EF1843
is not detected under laboratory conditions but is produced upon exposure to lysozyme. Previous work did not reveal any peptidoglycan structure modification associated with the deletion of EF1843, suggesting that the corresponding protein is not expressed under laboratory conditions, or that its activity was below detection thresholds. Western blot analyses indicated that the protein could not be detected in E. faecalis crude extracts when the cells were grown in rich medium (Fig. 1A, lane 1) . In contrast, when the cells had been grown in the presence of lysozyme, a band corresponding to the expected protein size could be detected (Fig.  1A, lanes 2 to 4) and was absent in the ⌬EF1843 mutant extracts (Fig. 1A, lane 5) . These results indicated that EF1843 protein is specifically produced upon exposure to lysozyme.
EF1843 is involved in peptidoglycan GlcNAc de-N-acetylation. Previous studies showed that EF1843 deletion has no impact on E. faecalis peptidoglycan structure when the cells are grown in rich medium (24) . To investigate EF1843-dependent peptidoglycan modifications, we used strain SAS (pMSP3535-sigV), a JH2-2 derivative with a nisin-inducible sigV copy (30) . Nisin induction of sigV results in around a 2,000-fold increase in EF1843 transcription compared to that with the control strain, SAS(pMSP3535), harboring the empty vector (30) . After induction of EF1843 (Fig.  1B) , peptidoglycan was purified and digested by mutanolysin, and the soluble muropeptides were reduced prior to rp-HPLC separation (Fig. 2) . The muropeptide profile of the control strain, SAS(pMSP3535), harboring the empty vector ( Fig. 2A) , was virtually identical to the profile of the ⌬EF1843 mutant and to that of JH2-2 that had not been exposed to lysozyme (24) . After induction of sigV and EF1843 by nisin and lysozyme, several peaks appeared (Fig. 2B, peaks 1 to 8 ). MS analyses of these peaks revealed that they all contained muropeptides with m/z values matching those of deacetylated disaccharide-peptides (Fig. 2E) . To further investigate the contribution of EF1843 to peptidoglycan deacetylation, E. faecalis JH2-2 and its isogenic ⌬EF1843 deletion mutant were grown in the presence of lysozyme, which we have shown to induce EF1843 production (Fig. 1C) . The muropeptide profiles of the parental (Fig. 2C ) and the mutant peptidoglycan (Fig. 2D) were overall very similar. However, a few peaks detected in the SAS(pMSP3535-sigV) muropeptide profile (Fig. 2B) were present in small amounts in the JH2-2 profile (labeled 1, 2, 3, and 5 in Fig.  2C ) and absent from the ⌬EF1843 mutant profile (Fig. 2D) . MS analysis confirmed the presence of deacetylated muropeptides in JH2-2 peaks 1, 2, 3, and 5, whereas no deacetylated muropeptides were detected in peak 1=, 2=, or 3=. The structure of the most abundant muropeptide corresponding to peak 3, matching the calculated mass of a disaccharide-pentapeptide with two alanyl residues as a lateral chain, was analyzed by electrospray tandem mass spectrometry (MS-MS) (Fig. 2F) . Loss of a de-N-acetylated glucosamine residue (GlcN; Ϫ161.07) gave an ion at m/z 907.48. Additional loss of alanyl residues from the C terminus of the pentapeptide or the N terminus of the side chain gave additional ions characteristic of the muropeptides generated by mutanolysin (14) . Together, our results therefore suggested that EF1843 is required for peptidoglycan GlcNAc de-N-acetylation.
In vitro N-acetylglucosamine deacetylase activity of recombinant EF1843. Chitooligosaccharides (2 to 6 residues) were used as substrates to assay EF1843 deacetylase activity in vitro (Fig. 3) . Incubation of hexa-N-acetyl chitohexaose in the presence of EF1843 leads to the appearance of several ions with m/z values matching the loss of one to four acetyl groups (Fig. 3) . Similarly, ions with m/z values matching deacetylation products were detected with the other chitooligosaccharides used as substrates, except for diacetyl chitobiose and GlcNAc (see Fig. S2 in the supple- mental material; other data not shown). Together, these results showed that EF1843 is an N-acetylglucosamine deacetylase, which we renamed PgdA.
PgdA-mediated peptidoglycan deacetylation inhibits lysozyme activity. Deletion of pgdA alone had no impact on lysozyme resistance level, with a MIC of Ͼ50 mg/ml, similar to that of the parental strain (24) . Since previous studies revealed an additive contribution of several genes to lysozyme resistance in E. faecalis (30) , pgdA deletion was combined with mutations in other genes involved in lysozyme resistance. Introduction of the pgdA deletion in a triple oatA dltA sigV mutant genetic background slightly decreased lysozyme resistance, indicating that peptidoglycan deacetylation contributes to protection of E. faecalis against lysozyme (Fig. 4A) . However, the very limited contribution of PgdA to lysozyme resistance in a triple mutant background was expected in the absence of SigV that positively regulates pgdA expression. The contribution of PgdA to lysozyme resistance was therefore confirmed using strain SAS(pMSP3535-sigV), which allows massive overexpression of pgdA under the control of nisin (Fig. 1) . For comparison purposes, we developed a gradient plate system, allowing fine-tuning of pgdA expression (using up to 0.5 g/ml nisin), in conjunction with exposure to variable amounts of lysozyme (up to 5 mg/ml). Both the parental JH2-2 and pgdA strains grew normally in the presence of lysozyme at 5 mg/ml (Fig.  4B, lanes 1 and 6) . In contrast, the growth of the oatA dltA sigV triple and the oatA dltA sigV pgdA quadruple mutants was inhibited by the lowest concentration of lysozyme used (Fig. 4B, lanes 2  and 3) . Incorporation of nisin in the growth medium at a concentration that induces sigV expression (0.5 g/ml) had no impact on cell viability or lysozyme resistance of the parental or pgdA strain (Fig. 4B, lanes 1 and 6) . In the triple oatA dltA sigV mutant, nisin induction of sigV restored growth in the presence of the highest concentration of lysozyme used (Fig. 4B, lane 4) . In contrast, upon induction of sigV, the nisin-dependent lysozyme resistance was strongly reduced in the quadruple oatA dltA sigV pgdA mutant (Fig. 4B, lane 5) , demonstrating that the resistance to lysozyme conferred by SigV overexpression is mediated by PgdA. These results were confirmed by semiquantitative assays (30) using nisin (0.5 g/ml) in combination with variable amounts of lysozyme (see Fig. S3A in the supplemental material) .
To understand the mechanism by which PgdA mediates lysozyme resistance, we assayed the bactericidal effect of heat-denatured lysozyme. It has been shown previously that heat denaturation of lysozyme inactivates its catalytic activity while preserving its antimicrobial activity (25) . Interestingly; gradient plate assays revealed that heat-denatured lysozyme was still highly active on the triple oatA dltA sigV mutant (Fig. 4C, lane 2) , indicating that the catalytic activity of lysozyme against E. faecalis is not essential. Semiquantitative assays revealed that approximately twice as much heat-inactivated lysozyme is required to give growth inhibition similar to that given by native lysozyme (for example, compare 2-mg/ml and 4-mg/ml concentrations in Fig. S3A and S3B, respectively, in the supplemental material). In both gradient plates (Fig. 4C ) and semiquantitative assays (Fig. S3B) , the comparison of the triple oatA dltA sigV and the quadruple oatA dltA sigV pgdA mutants showed that PgdA had only a marginal effect on the antimicrobial peptide bactericidal effect of lysozyme. We therefore concluded that peptidoglycan deacetylation by PgdA inhibited both lysozyme catalytic activity and, to a lesser extent, lysozyme antimicrobial peptide activity. pgdA deletion had no clear impact on the bactericidal activity of three other cationic antimicrobial peptides: pexiganan (21), polymyxin B, and nisin (see Fig. S4 in the supplemental material).
PgdA contributes to E. faecalis virulence. We used G. mellonella as an animal model (20, 28, 31, 32) to compare virulence of the parental JH2-2 strain, its isogenic pgdA mutant, and the complemented mutant. Three independent experiments were carried out using JH2-2 and the pgdA deletion mutant, both harboring the empty vector used for complementation, as well as the complemented pgdA mutant (Fig. 5A to C) . In the combined results (Fig.  5D ), significant differences in mortality rates were noted between the parental and mutant strains (log rank test; P Ͻ 0.0001). As expected, complementation of the pgdA deletion partially restored mortality rates comparable to those of the parental strain (Fig. 5D) , and in the control group infected with sterile saline solution, no larvae died in any of the replicates (data not shown). These results therefore showed that pgdA contributes to the virulence of E. faecalis.
DISCUSSION
Based on sequence homology, EF1843 was previously identified as a putative peptidoglycan deacetylase in E. faecalis (24) . However, peptidoglycan deacetylation modification has not been reported so far for E. faecalis (15, 24) , and previous studies did not reveal any contribution of EF1843 to peptidoglycan structure under laboratory conditions. Our objectives were to identify the role of E. faecalis EF1843 in resistance to lysozyme and to test its contribution to the virulence of this opportunistic pathogen.
EF1843 transcription is regulated by V , an ECF sigma factor involved in lysozyme resistance (3, 30) . Our results revealed that E. faecalis peptidoglycan deacetylation occurs after exposure to lysozyme, suggesting that EF1843 is an effector of the V signaling cascade induced by lysozyme (30) . We showed that lysozyme triggers the production of EF1843 and that, in turn, this protein deacetylates GlcNAc residues in peptidoglycan. This mechanism, which allows E. faecalis to sense one of the components of the host innate immune response, is reminiscent of that described for Streptococcus suis (18) . In S. suis, peptidoglycan de-N-acetylation is extremely low when the cells are grown in rich medium. Although the host signal(s) inducing peptidoglycan de-N-acetylation has not been identified, the expression of S. suis deacetylase is strongly stimulated in vivo (18) .
Both E. faecalis and S. aureus can tolerate very high lysozyme concentrations (up to 50 mg/ml) compared to other Gram-positive bacteria such as Listeria monocytogenes (6) or Streptococcus pneumoniae (43) . These high resistance levels rely on two main mechanisms: (i) peptidoglycan O-acetylation mediated by oatA and (ii) modification of the negative net charge of the bacterial cell envelope through addition of D-alanine residues on teichoic and lipoteichoic acids, mediated by dlt genes (30) . Whereas oatA inactivation has similar effects on the MIC of lysozyme in both E. faecalis and S. aureus (ca. 5-fold decrease), dltA inactivation has a more pronounced effect in S. aureus than in E. faecalis (25-fold decrease in lysozyme MIC versus 5-fold, respectively). Interestingly, oatA and dltA mutations have a synergistic effect in S. aureus (10,000-fold reduction of the MIC) and at best an additive effect in E. faecalis (25-fold reduction of the MIC). Previous studies have shown that S. aureus oatA and dltA are part of the graRS regulon, which includes 248 genes (25) . It is therefore tempting to assume that in S. aureus, the synergy between oatA and dltA results from other mechanisms triggered by a complex feedback control involving graRS. In E. faecalis, the key transcriptional regulator orchestrating lysozyme resistance is V . E. faecalis V does not regulate the expression of dltA or oatA (30), contrary to B. subtilis V (22, 26) . As a consequence, high-level resistance to lysozyme in E. faecalis is achieved through three distinct pathways leading to cell wall modifications (involving sigV, oatA, and dltA). Interestingly, we showed that E. faecalis harboring simultaneous deletions of oatA, dltA, sigV, and pgdA still displays resistance to lysozyme (Fig. 4A) . Previous studies showed that addition of L-lysine on phosphatidylglycerol by the multiple peptide resistance factor (MprF) described for S. aureus (16) does not contribute to lysozyme resistance in E. faecalis (30) . Moreover, no homolog of the lysozyme inhibitors found in Gram-negative (1, 8, 39, 40) or Gram-positive (5) bacteria is found in the E. faecalis genome. Therefore, other mechanisms responsible for the unusual resistance to lysozyme are yet to be identified in E. faecalis.
Peptidoglycan deacetylation has been reported as a virulence factor in a number of important pathogens such as Listeria monocytogenes (2, 35) , S. pneumoniae (12) , S. suis (18) , and S. aureus (4) . In this study, we also showed its involvement in E. faecalis virulence in an insect infection model. In conclusion, E. faecalis appears to have evolved one of the most complex combinations of lysozyme resistance mechanisms among Grampositive bacteria. This unique arsenal ensures the capacity of this organism to thrive inside mammalian hosts, both as a commensal and as a pathogen.
